These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1352903)

  • 1. L-deprenyl in treating negative symptoms of schizophrenia.
    Perenyi A; Goswami U; Frecska E; Arató M; Bela A
    Psychiatry Res; 1992 May; 42(2):189-91. PubMed ID: 1352903
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of negative symptoms in schizophrenia and schizoaffective disorder by selegiline augmentation of antipsychotic medication. A pilot study examining the role of dopamine.
    Bodkin JA; Cohen BM; Salomon MS; Cannon SE; Zornberg GL; Cole JO
    J Nerv Ment Dis; 1996 May; 184(5):295-301. PubMed ID: 8627275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind, placebo-controlled, multicenter trial of selegiline augmentation of antipsychotic medication to treat negative symptoms in outpatients with schizophrenia.
    Bodkin JA; Siris SG; Bermanzohn PC; Hennen J; Cole JO
    Am J Psychiatry; 2005 Feb; 162(2):388-90. PubMed ID: 15677608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A placebo-controlled trial of selegiline (L-deprenyl) in the treatment of tardive dyskinesia.
    Goff DC; Renshaw PF; Sarid-Segal O; Dreyfuss DA; Amico ET; Ciraulo DA
    Biol Psychiatry; 1993 May; 33(10):700-6. PubMed ID: 8102552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of selegiline add on therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study.
    Amiri A; Noorbala AA; Nejatisafa AA; Ghoreishi A; Derakhshan MK; Khodaie-Ardakani MR; Hajiazim M; Raznahan M; Akhondzadeh S
    Hum Psychopharmacol; 2008 Mar; 23(2):79-86. PubMed ID: 17972359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selegiline augmentation of antipsychotics for the treatment of negative symptoms in schizophrenia.
    Gupta S; Droney T; Kyser A; Keller P
    Compr Psychiatry; 1999; 40(2):148-50. PubMed ID: 10080262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treating negative symptoms.
    Bailey P; Duval F; Macher JP
    Br J Psychiatry; 1994 May; 164(5):699-700. PubMed ID: 7921730
    [No Abstract]   [Full Text] [Related]  

  • 8. Adjunctive clonazepam in the treatment of chronic schizophrenia.
    Herrera JM; Alvarez WA; Freinhar JP; Lawson WB; Sramek JJ
    Int J Psychosom; 1991; 38(1-4):17-20. PubMed ID: 1685726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyproheptadine in treatment-resistant chronic schizophrenics with prior negative response to fluoxetine.
    Bacher NM; Sanzone MM; Kaup B
    J Clin Psychopharmacol; 1994 Dec; 14(6):424-5. PubMed ID: 7884024
    [No Abstract]   [Full Text] [Related]  

  • 10. Negative symptoms of schizophrenia are improved by paroxetine added to neuroleptics: a pilot study.
    Jockers-Scherübl M; Godemann F; Pietzcker A
    J Clin Psychiatry; 2001 Jul; 62(7):573. PubMed ID: 11488373
    [No Abstract]   [Full Text] [Related]  

  • 11. Positive and negative symptoms in schizophrenia: where are the data?
    de Leon J; Simpson GM; Peralta V
    Biol Psychiatry; 1992 Mar; 31(5):431-4. PubMed ID: 1349829
    [No Abstract]   [Full Text] [Related]  

  • 12. The treatment of negative symptoms: pharmacological and methodological issues.
    Carpenter WT
    Br J Psychiatry Suppl; 1996 May; (29):17-22. PubMed ID: 8733819
    [No Abstract]   [Full Text] [Related]  

  • 13. Negative symptoms, tardive dyskinesia and depression in chronic schizophrenia.
    Barnes TR; Liddle PF; Curson DA; Patel M
    Br J Psychiatry Suppl; 1989 Nov; (7):99-103. PubMed ID: 2575915
    [No Abstract]   [Full Text] [Related]  

  • 14. Deprenyl augmentation for treating negative symptoms of schizophrenia: a double-blind, controlled study.
    Jungerman T; Rabinowitz D; Klein E
    J Clin Psychopharmacol; 1999 Dec; 19(6):522-5. PubMed ID: 10587287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The therapeutic role of naltrexone in negative symptom schizophrenia.
    Marchesi GF; Santone G; Cotani P; Giordano A; Chelli F
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 Dec; 19(8):1239-49. PubMed ID: 8868206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Depressive symptoms in schizophrenia].
    Gerard A
    Encephale; 1998 Jul; 24 Spec No 1():24-6. PubMed ID: 9809250
    [No Abstract]   [Full Text] [Related]  

  • 17. Topiramate for refractory schizophrenia.
    Millson RC; Owen JA; Lorberg GW; Tackaberry L
    Am J Psychiatry; 2002 Apr; 159(4):675. PubMed ID: 11925318
    [No Abstract]   [Full Text] [Related]  

  • 18. Clozapine augmented with aripiprazole in 5 patients with schizophrenia.
    Abu-Tair F; Kopitz J; Bergemann N
    J Clin Psychopharmacol; 2006 Dec; 26(6):669-71. PubMed ID: 17110831
    [No Abstract]   [Full Text] [Related]  

  • 19. An open study of buspirone augmentation of neuroleptics in patients with schizophrenia.
    Sirota P; Epstein B; Benatov R; Sousnostzky M; Kindler S
    J Clin Psychopharmacol; 2001 Aug; 21(4):454-5. PubMed ID: 11476132
    [No Abstract]   [Full Text] [Related]  

  • 20. Pimozide augmentation for the treatment of schizophrenic patients who are partial responders to clozapine.
    Friedman J; Ault K; Powchik P
    Biol Psychiatry; 1997 Sep; 42(6):522-3. PubMed ID: 9285089
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.